Statistics
Publications
80
Citations
5.5K
H-Index
40
Active since
1992
Yong‐Mi Kim is an author at University of Southern California specializing in oncology, molecular oncology, and medicine.
Publications per year
1992–2024
80
80
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan, Xuan Zhang, Dongwen Lv et al. · Nature Medicine · 2019 · 647 citations · Full text
Medicine, Oncology, Pharmacology +7
Markus Y. Mapara, Yong‐Mi Kim, Shengping Wang et al. · Blood · 2002 · 237 citations · Full text
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition
Cihangir Duy, Christian Hurtz, Seyedmehdi Shojaee et al. · Nature · 2011 · 204 citations
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
Kristen Fousek, Junji Watanabe, Sujith K. Joseph et al. · Leukemia · 2020 · 184 citations · Full text
1–5 of 80